Phase II study of Carboplatin, Paclitaxel and Bevacizumab in patients with advanced Non-squamous non-small-cell lung cancer with large malignant pleural effusion.
Phase 2
- Conditions
- on-squamous non-small-cell lung cancer
- Registration Number
- JPRN-UMIN000006767
- Lead Sponsor
- Shizuoka Cancer Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 32
Inclusion Criteria
Not provided
Exclusion Criteria
1) Actuve concomitant malignancy 2) Massive pericardial effusion 3) With rain metastasis, or tumor with large vessel invasion or cavity formation 4) Episode of hemoptysis 5) Those judged to be not suitable by the attending physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method